Research programme: engineered T cells - Cell Design Labs

Drug Profile

Research programme: engineered T cells - Cell Design Labs

Alternative Names: CellBot™ therapy; synNotch™ T-cells

Latest Information Update: 10 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cell Design Labs
  • Class T lymphocyte cell therapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Autoimmune disorders; Cancer

Most Recent Events

  • 07 Jun 2017 Cell Design Labs has patent protection for synNotch™ technology in USA
  • 09 Feb 2017 Cell Design Labs plans a phase I trial in 2018
  • 29 Sep 2016 Preclinical trials in Cancer and Autoimmune disorders in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top